USE OF TISSUE-PLASMINOGEN ACTIVATOR FOR REOPENING OF CLOTTED DIALYSIS CATHETERS

被引:38
|
作者
PAULSEN, D
REISAETHER, A
AASEN, M
FAUCHALD, P
机构
[1] Medical Department B, National Hospital of Norway, N-0027 Oslo-1
来源
NEPHRON | 1993年 / 64卷 / 03期
关键词
HEMODIALYSIS; CENTRAL VENOUS CATHETERS; FIBRINOLYTIC AGENTS; TISSUE PLASMINOGEN ACTIVATOR;
D O I
10.1159/000187374
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The use of central venous catheters as permanent vascular access in chronic hemodialysis is complicated by clotting. We have tried a nonallergenic thrombolytic agent, tissue plasminogen activator (t-PA), to dissolve catheter luminal thrombosis. Eight patients, 7 in chronic hemodialysis and 1 treated by immune adsorption had 18 treatments with locally applied t-PA (2 mg/2 cm3). Fifteen out of 16 treatments with longer bolus dwell than 60 min were successful. No side effects occurred. t-PA dissolves clot formation efficiently and safely, the drug is nonallergenic and can therefore be given repeatedly.
引用
收藏
页码:468 / 470
页数:3
相关论文
共 50 条
  • [21] INCREASING THE FIBRIN SPECIFICITY OF TISSUE-PLASMINOGEN ACTIVATOR
    CHOW, AM
    PENA, LC
    KEYT, BA
    ZOLLER, MJ
    BENNETT, WF
    PAONI, NF
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 762 - 762
  • [22] THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR IN NEONATES
    HO, CK
    DANNAWI, H
    HAM, WL
    CONNER, ED
    CLINICAL RESEARCH, 1993, 41 (04): : A814 - A814
  • [23] TREATMENT OF INTRAVENTRICULAR HEMORRHAGE WITH TISSUE-PLASMINOGEN ACTIVATOR
    FINDLAY, JM
    GRACE, MGA
    WEIR, BKA
    HAINES, SJ
    SAWAYA, R
    NEUROSURGERY, 1993, 32 (06) : 941 - 947
  • [24] Reduction of leukocyte activation by tissue-plasminogen activator
    Krapohl, B
    Perez, P
    Browne, E
    Zins, J
    Siemionow, M
    7TH CONGRESS OF THE INTERNATIONAL FEDERATION OF SOCIETIES FOR SURGERY OF THE HAND (IFSSH), 1998, : 57 - 60
  • [25] EFFECT OF HEPARIN AND PROTAMINE ON PLASMINOGEN ACTIVATION BY TISSUE-PLASMINOGEN ACTIVATOR
    BOHM, T
    GEIGER, M
    BINDER, BR
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1352 - 1352
  • [26] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE
    MARLER, JR
    BROTT, T
    BRODERICK, J
    KOTHARI, R
    ODONOGHUE, M
    BARSAN, W
    TOMSICK, T
    SPILKER, J
    MILLER, R
    SAUERBECK, L
    JARRELL, J
    KELLY, J
    PERKINS, T
    MCDONALD, T
    RORICK, M
    HICKEY, C
    ARMITAGE, J
    PERRY, C
    THALINGER, K
    RHUDE, R
    SCHILL, J
    BECKER, PS
    HEATH, RS
    ADAMS, D
    REED, R
    KLEI, M
    HUGHES, S
    ANTHONY, J
    BAUDENDISTEL, D
    ZADICOFF, C
    RYMER, M
    BETTINGER, I
    LAUBINGER, P
    SCHMERLER, M
    MEIROSE, G
    LYDEN, P
    RAPP, K
    BABCOCK, T
    DAUM, P
    PERSONA, D
    BRODY, M
    JACKSON, C
    LEWIS, S
    LISS, J
    MAHDAVI, Z
    ROTHROCK, J
    TOM, T
    ZWEIFLER, R
    DUNFORD, J
    ZIVIN, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24): : 1581 - 1587
  • [27] IS TISSUE-PLASMINOGEN ACTIVATOR REALLY SUPERIOR TO STREPTOKINASE
    DIAMOND, GA
    DENTON, TA
    FORRESTER, JS
    SHAH, PK
    CIRCULATION, 1993, 88 (04) : 452 - 452
  • [28] Binding of tissue-plasminogen activator to fibrin: Effect of ultrasound
    Siddiqi, F
    Odrljin, TM
    Fay, PJ
    Cox, C
    Francis, CW
    BLOOD, 1998, 91 (06) : 2019 - 2025
  • [29] EFFECT OF PREOPERATIVE TISSUE-PLASMINOGEN ACTIVATOR IN POSTOPERATIVE ENDOPHTHALMITIS
    FOSTER, RE
    SCHWAM, BL
    LEWIS, H
    PRATTRIPPIN, K
    HALL, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S790 - S790
  • [30] TISSUE-PLASMINOGEN ACTIVATOR IN PATIENTS WITH LUPUS NEPHRITIS (LN)
    POLYANTSEVA, LG
    BOBKOVA, IN
    TAREEVA, IY
    PODOROLSKAYA, LV
    ANDREENKO, GV
    TERAPEVTICHESKII ARKHIV, 1995, 67 (05) : 17 - 19